BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia.

類似資料

• BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia
  著者:: Buitenkamp, T, 等
  出版事項: (2013)
• Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
  著者:: Buitenkamp, T, 等
  出版事項: (2012)
• Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.
  著者:: Buitenkamp, T, 等
  出版事項: (2012)
• Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia
  著者:: Trudy D. Buitenkamp, 等
  出版事項: (2010-07-01)
• Delineation of Risk Factors in Paediatric Acute Lymphoblastic Leukaemia with Favourable Cytogenetics
  著者:: Moorman, A, 等
  出版事項: (2012)